Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Novo Nordisk requests approval for new type 2 treatment with heart benefits.
Read More »New Oral GLP-1 Application Submitted to FDA
Using Glycemic Variability To Predict Major Cardiac Events In Patients with Type 2 Diabetes
Too many highs and lows in glucose levels could be another reason that causes cardiovascular complications.
Read More »Does Intensive Blood Pressure Control Prevent Strokes?
Maintaining a blood pressure below 130/80 mm Hg can eventually reduce the risk of having a repeat stroke, according to a recent study.
Read More »Newsflash: Hormone Levels May Predict PCOS in Premenarchal Girls
Research suggests testosterone and AMH levels could be used to predict risk for PCOS in premenarchal daughters of women with PCOS.
Read More »The Effect of Metformin On Patients Who Are Pregnant and Have PCOS
Treatment throughout pregnancy may reduce rate of miscarriage or preterm delivery.
Read More »Does Canagliflozin Increase Risk of Fracture In Patients With Diabetes?
CANVAS Program shows reduced heart events but increased risk of side effects.
Read More »Diabetic Ketoacidosis and The Developing Brain
Single episode of moderate/severe DKA in young children at diagnosis associated with lower cognitive scores, altered brain growth.
Read More »Diabetes and Chronic Kidney Disease
Older adults with diabetes and chronic kidney disease (CKD) are at an increased risk of cognitive impairment and dementia, frailty, dysglycemia, and polypharmacy.
Read More »Gestational Diabetes Effects on Childhood Glucose Metabolism
Children of mothers with untreated gestational diabetes mellitus are at risk of insulin resistance and impairment in glucose metabolism.
Read More »Metformin Safety In Patients With Chronic Kidney Disease And Its Benefits
In patients with stage 3 kidney disease, metformin use may be safe and may reduce the risk of mortality and cardiovascular events.
Read More »